Since IDE-deficient mice show accumulation of Aβ protein [15], hyperinsulinemia and glucose intolerance enhancing or emulating the activity of IDE may lower the Aβ burden and may be of interest to pursue as an AD-treatment. The gene discussed is IDE; the disease is hyperinsulinism.